Radiation Therapy for Carcinoma of the Prostate: 5-Year Followup
- 1 February 1977
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 117 (2) , 214-215
- https://doi.org/10.1016/s0022-5347(17)58405-0
Abstract
The original series of patients with prostatic carcinoma treated with irradiation as the initial modality was updated. The overall 5 yr survival rate for patients with stage III carcinoma of the prostate was 55%; 26% were alive with residual disease and had postirradiation hormone manipulation, while 29% were alive without metastases at 5 yr.This publication has 18 references indexed in Scilit:
- Definitive Radiation Therapy of Carcinoma of the ProstateRadiology, 1973
- Complications and Regression of Primary Tumor Size with Radiotherapy in Prostatic CancerJournal of Urology, 1972
- Radiotherapy in the Treatment of Locally Infiltrating Carcinoma of the ProstateJournal of Urology, 1972
- Biopsy-Proved Tumor Following Definitive Irradiation for Resectable Carcinoma of the ProstateJournal of Urology, 1972
- Cobalt 60 Teletherapy of Localized Prostatic Carcinoma: A 10-year ExperienceJournal of Urology, 1971
- The Use of Cobalt 60 Teletherapy in the Treatment of Prostatic CarcinomaJournal of Urology, 1968
- Treatment of Carcinoma of the Prostate by Cobalt-Beam TherapyRadiology, 1968
- Radiotherapy in the Conservative Treatment of Operable and Locally Inoperable Carcinoma of the ProstateRadiology, 1967
- AN ASSESSMENT OF THE VALUE OF RADIOTHERAPY IN THE MANAGEMENT OF CARCINOMA OF THE PROSTATEBritish Journal of Urology, 1964
- Treatment of Carcinoma of the Prostate by Interstitial Radiation with Radio-Active Gold (Au198): A Preliminary ReportJournal of Urology, 1952